Azinolt-250 by Norchem Healthcare: Trusted Antibiotic for Bacterial Infections

In the fight against bacterial infections, macrolide antibiotics play a critical role due to their wide coverage, safety profile, and patient convenience. Azinolt-250, a premium product from Norchem Healthcare, is formulated with Azithromycin 250 mg, a widely prescribed antibiotic used by general practitioners, pediatricians, and ENT specialists alike. Known for its rapid action, once-daily dosing, and broad-spectrum efficacy, Azinolt-250 stands out as a reliable and affordable choice in antibiotic therapy.

Product Name:

Azinolt-250 Tablet

Manufactured by:

Norchem Healthcare – a leading pharmaceutical company committed to delivering quality-driven and patient-centric healthcare solutions.

Composition of Azinolt-250

• Azithromycin 250 mg
   

Azithromycin is a macrolide antibiotic that works by inhibiting bacterial protein synthesis, preventing their growth and multiplication. Azinolt-250 offers targeted treatment of mild to moderately severe infections, with once-daily convenience and enhanced patient adherence.

Pharmacology: How Azithromycin Works

Azithromycin binds to the 50S subunit of the bacterial ribosome, inhibiting the translocation steps in protein synthesis. It has a bacteriostatic effect at low concentrations and bactericidal effect at higher concentrations.

Key features of its pharmacokinetics:

• Excellent tissue penetration
   
• Long half-life (allows once-daily dosing)
   
• Sustained action even after completion of therapy
   

Azithromycin is especially effective against:

• Streptococcus pneumoniae
   
• Haemophilus influenzae
   
• Moraxella catarrhalis
   
• Chlamydia trachomatis
   
• Mycoplasma pneumoniae
   

Indications: When to Prescribe Azinolt-250

Azinolt-250 is effective in treating a broad range of infections, including:

1. Respiratory Tract Infections

• Acute bronchitis
   
• Bacterial sinusitis
   
• Community-acquired pneumonia
   
• Pharyngitis and tonsillitis
   

2. ENT Infections

• Otitis media (middle ear infection)
   
• Laryngitis
   
• Rhinosinusitis
   

3. Skin and Soft Tissue Infections

• Cellulitis
   
• Folliculitis
   
• Infected wounds or abscesses
   

4. Urogenital Infections

• Uncomplicated urethritis and cervicitis caused by Chlamydia trachomatis
   

5. Gastrointestinal Infections

• Traveler’s diarrhea caused by Campylobacter jejuni
   

6. Typhoid Fever (Mild to Moderate Cases)

Azithromycin has emerged as an effective option for typhoid in areas with multi-drug resistance.

Benefits of Azinolt-250

 Once-Daily Dosing

With its extended half-life, Azinolt-250 requires just one dose per day, improving adherence among patients and children.

 Short Treatment Duration

Typical regimens last 3 to 5 days, significantly shorter than many other antibiotics.

 Well-Tolerated

Azithromycin is known for its gastrointestinal tolerability compared to other macrolides.

Excellent Tissue Penetration

It concentrates in infected tissues and cells, delivering superior therapeutic results.

 Safe in Pediatrics and Adults

Can be safely prescribed to children, adolescents, and adults under proper medical guidance.

Dosage & Administration

Adults:

• Standard dose: One tablet (250 mg) once daily for 3 to 5 days, depending on infection type and severity.
   
• For mild to moderate respiratory or skin infections: 500 mg on Day 1, followed by 250 mg once daily on Days 2–5.
   

Children:

• Pediatric dosing is based on body weight (typically 10 mg/kg on Day 1, followed by 5 mg/kg/day on Days 2–5).
   
• Available in dry syrup formulation for children.
   

Note: It is advised to take the medicine 1 hour before or 2 hours after meals for optimal absorption.

Side Effects

While Azinolt-250 is generally safe and well-tolerated, some patients may experience:

• Nausea and vomiting
   
• Diarrhea
   
• Abdominal pain
   
• Headache
   
• Mild skin rashes
   

Rare but serious adverse effects:

• Liver enzyme elevation
   
• QT prolongation (in cardiac patients)
   
• Allergic reactions (anaphylaxis)
   
• Hearing changes (in long-term use)
   

Patients are advised to inform their healthcare provider if any severe or persistent side effects occur.

Precautions and Warnings

• Avoid in patients with known allergy to macrolides.
   
• Use cautiously in patients with liver dysfunction or prolonged QT interval.
   
• Avoid co-administration with drugs that prolong QT interval (e.g., certain antifungals, antipsychotics).
   
• Use in pregnancy or lactation only when clearly needed and prescribed by a doctor.
   
• Always complete the full course of therapy to avoid resistance.
   

Storage Instructions

• Store below 25°C in a cool, dry place.
   
• Protect from direct sunlight and moisture.
   
• Keep out of reach of children.
   

Why Doctors Recommend Azinolt-250

Healthcare professionals consistently choose Azinolt-250 because it provides:

• Fast and effective resolution of symptoms
   
• Short-course therapy with less antibiotic burden
   
• Fewer gastrointestinal disturbances
   
• Trusted safety record across age groups
   

Whether for pediatric patients with ear infections or adults battling bronchitis, Azinolt-250 delivers consistent and reliable results.

Azinolt-250 and the PCD Pharma Franchise Model

As one of the top-performing antibiotics in the Indian pharma market, Azinolt-250 represents a golden opportunity for PCD pharma franchise partners under the Norchem Healthcare banner.

 Why Partner with Norchem Healthcare?

• WHO-GMP certified manufacturing
   
• Attractive monopoly rights in your area
   
• Competitive pricing and profit margins
   
• Promotional materials: visual aids, MR bags, samples
   
• Quick and assured delivery
   
• Transparent and ethical business model
   

 Market Potential

With growing bacterial resistance and rising infection rates, the demand for high-quality, fast-acting antibiotics like Azithromycin is constantly increasing. Azinolt-250 stands out in this space due to its quality assurance and trusted results.

Whether you’re an existing distributor or a new entrepreneur entering the pharma sector, adding Azinolt-250 to your portfolio ensures both clinical value and business growth.

Conclusion

Azinolt-250 by Norchem Healthcare is a well-established, clinically effective macrolide antibiotic that offers optimal outcomes for a wide range of infections. Its once-daily dosing, broad-spectrum activity, and shorter treatment course make it a preferred choice among physicians and patients alike.

Supported by Norchem Healthcare’s commitment to quality, innovation, and healthcare excellence, Azinolt-250 is more than just a medicine—it is a promise of better health and a stronger future for both patients and pharma partners.